CARDIOGENIC SHOCK POST AMI

Monday, March 10, 2025

3:30 PM - 4:30 PM ET

Moderator(s)

Gregg W. Stone, MD, FACC, MSCAI

Physician
Mount Sinai
New York, New York, United States

Disclosure information not submitted.

Panel Discussant(s)

Lindsey Cilia, MD

Co-Director of Complex Coronary Therapeutics Program Interventional Cardiologist
Inova Heart and Vascular Institute/Virginia Heart
Falls Church, Virginia, United States

No relationships to disclose
Ramesh Daggubati, MD, FACC, FSCAI

Vice Chair of the Department of Cardiology & Chief of Interventional Cardiology
JW Ruby Memorial Hospital, West Virginia University
Morgantown, West Virginia, United States

Disclosure information not submitted.
Dean J. Kereiakes, MD, FACC, MSCAI

Chairman, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
The Christ Hospital Health Network
Cincinnati, Ohio, United States

No relationships to disclose
Tanveer Rab, MD, FACC, MSCAI

Professor
Emory University
Decatur, Georgia, United States

No relationships to disclose
Michael J. Rinaldi, MD

Director Structural Heart Program
Sanger Heart and Vascular Institute/Atrium Health
Charlotte, North Carolina, United States

Disclosure information not submitted.
George W. Vetrovec, MD, MACC, MSCAI

Professor Emeritus
VCU Pauley Heart Center
Richmond, Virginia, United States

Disclosure information not submitted.
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)

Disclosure(s):

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Cardiovascular Systems Inc, Phillips, Vascular Dynamics, Pulnovo, V-wave: Research support to Mount Sinai Hospital (Ongoing); Apollo Therapeutics, Cardiac Success, Occlutech, Millennia Biopharma, RCE, Ablative Solutions, Abbott: Consultant (Terminated); Boehringer Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cardiac Success, Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Valfix, Xenter: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave, Biosense-Webster, Bioventrix: Research support to Mount Sinai Hospital (Terminated); Valfix, Zoll, HeartFlow, Shockwave, Ancora, Impulse Dynamics, Adona Medical, Oxitope, HighLife, Elixir, Elucid Bio, Aria, Alleviant, FBR Medical: Consultant (Ongoing)

Lindsey Cilia, MD: No financial relationships to disclose

Ramesh Daggubati, MD, FACC, FSCAI: medtronic.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Dean J. Kereiakes, MD, FACC, MSCAI: Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Elixir Medical Corporation: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); JC Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Orchestra Biomed: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Sino Medical Sciences Technology, Inc.: Consultant (Ongoing)

Tanveer Rab, MD, FACC, MSCAI: No financial relationships to disclose

Michael J. Rinaldi, MD: Abbott Vascular,: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); abiomed: Consultant (Ongoing); boston scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); edwards: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); shockwave: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

George W. Vetrovec, MD, MACC, MSCAI: Abiomed: Consultant (Ongoing)

Ron Waksman, MD, MSCAI: Abbott Vascular: Grant/Research Support (Ongoing); Biotronik: Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Chiesi USA: Grant/Research Support (Ongoing)